P
PFE icon

Palladiem’s Pfizer PFE Stock Holding History

Palladiem’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$25K Sell
843
-211
-20% -$6.76K 0.04% 62
2015
Q2 		$34K Sell
1,054
-422
-29% -$13.8K 0.03% 72
2015
Q1 		$49K Sell
1,476
-5,428
-79% -$173K 0.04% 69
2014
Q4 		$204K Buy
+6,904
New +$198K 0.17% 34

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Palladiem's PFE Position: Q3 2015 in Review

Palladiem reduced its Pfizer (PFE) stake by 20% in Q3 2015, selling an estimated $6.76K and leaving 843 shares worth $25K. The position accounts for 0.04% of the portfolio, ranked #62.

Palladiem first reported a position in PFE in Q4 2014 and has held it in 4 quarters since. The position peaked at $204K in Q4 2014. 1,879 funds tracked by Wall St. Rank hold PFE as of Q3 2015.

  • Palladiem held 843 shares of Pfizer worth $25K as of Q3 2015.
  • Palladiem sold 211 Pfizer shares in Q3 2015, an estimated $6.76K.
  • Pfizer made up 0.04% of Palladiem's portfolio in Q3 2015, its #62 holding.
  • Palladiem first reported a position in Pfizer in Q4 2014 and has held it in 4 quarters since.
  • Palladiem's Pfizer position peaked at $204K in Q4 2014.
  • 1,879 funds tracked by Wall St. Rank held Pfizer as of Q3 2015.

Based on Palladiem's 13F filing for Q3 2015, filed 29 Oct 2015.